← Evidence map

ArticleBreast (Edinburgh, Scotland)2026

Withdrawal notice to: "From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2- breast cancer" [The Breast 88 (2026) 104791].

Paulina Stachyra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Withdrawal notice to: "From CDK4/6 to CDK2 and KAT: Evolving therapeutic approaches in HR+/HER2- breast cancer" [The Breast 88 (2026) 104791]. | OpenQuestion